{"gene":"CNTNAP2","run_date":"2026-04-28T17:28:53","timeline":{"discoveries":[{"year":2003,"finding":"Caspr2 (CNTNAP2) is required to maintain Kv1 (Shaker-like K+) channels at the juxtaparanodal region of myelinated axons, and this clustering depends on the interaction of Caspr2 with TAG-1 (an immunoglobulin-like cell adhesion molecule that binds Caspr2), forming a scaffold that organizes ion channels in the axonal membrane through axon-glia interactions.","method":"Gene-targeted knockout mice, immunostaining, co-localization studies","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular phenotype, replicated across multiple studies","pmids":["12963709"],"is_preprint":false},{"year":2001,"finding":"Caspr2 localization to the juxtaparanodal region depends on axon-glia interactions and the formation of paranodal barriers; in the absence of paranodal adhesion (CGT-/- or contactin KO mice), Caspr2 and Kv1.2 fail to relocate to juxtaparanodes and instead remain at paranodes, demonstrating that Caspr-containing barriers control the positioning of Caspr2.","method":"Analysis of mutant mice (CGT-/- and contactin KO) with immunostaining and developmental time-course experiments","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — multiple mutant mouse models, defined cellular phenotype, mechanistic epistasis","pmids":["11567047"],"is_preprint":false},{"year":2008,"finding":"Caspr2 clusters Kv1 channels at the juxtaparanodal region via its cytoplasmic domain but not via its carboxy-terminal PDZ-binding motif; PSD-93 and PSD-95 accumulate at the juxtaparanode in a Caspr2- and TAG-1-dependent manner; Caspr2 interacts with distinct scaffolding proteins through both PDZ- and protein 4.1-binding sequences as revealed by proteomics.","method":"Transgenic rescue experiments with deletion mutants (Caspr2dCT, Caspr2dPDZ) in Caspr2-null mice; co-immunoprecipitation; proteomic analysis","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1 — transgenic mutagenesis with functional rescue, proteomics, multiple orthogonal methods","pmids":["19109503"],"is_preprint":false},{"year":2008,"finding":"PSD-93, but not Caspr2, is required for clustering Kv1 channels at the axon initial segment (AIS); Caspr2 mediates Kv1 channel clustering at the juxtaparanode through a distinct mechanism independent of PSD-93.","method":"PSD-93 knockdown by RNAi in hippocampal neurons; PSD-93-/- knockout mice; comparison with Caspr2-null mice","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — clean KO mice with defined cellular phenotype, genetic epistasis between PSD-93 and Caspr2","pmids":["18509034"],"is_preprint":false},{"year":2010,"finding":"The interaction of Caspr2 with protein 4.1B is required for the accumulation of Caspr2 and Kv1 channels at the juxtaparanodal axonal membrane; a Caspr2 transgene lacking the 4.1B-binding sequence (Caspr2-d4.1) does not accumulate at the juxtaparanode, and Kv1 channels are not clustered at the juxtaparanode in 4.1B-null mice.","method":"Transgenic rescue experiments with 4.1-binding domain deletion mutants in Caspr2-null mice; analysis of 4.1B-null mice","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1 — transgenic domain-deletion rescue plus KO validation, multiple orthogonal approaches","pmids":["20164332"],"is_preprint":false},{"year":2009,"finding":"Caspr2 is targeted to the axonal surface through selective somatodendritic endocytosis; internalization from dendrites and cell body is dynamin-dependent and requires a PKC substrate motif at Thr1292 within the 4.1B-binding domain, as mutation of this residue or PKC inhibition prevents somatodendritic internalization.","method":"HA-tagged Caspr2 in hippocampal neurons, dominant-negative dynamin-1 or Dynasore treatment, site-directed mutagenesis (T1292 mutant), live-cell imaging","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis combined with pharmacological and dominant-negative approaches, functional readout","pmids":["19706678"],"is_preprint":false},{"year":2014,"finding":"Both Caspr and Caspr2 together are required for the radial (mesaxonal line) and longitudinal organization of Kv1 channels along myelinated peripheral axons; in Caspr/Caspr2 double-null mice, Kv1 channels are dispersed along the axolemma rather than confined to the internodal line, and nodes of Ranvier are widened, revealing compensatory functions between the two proteins.","method":"Double knockout mice (caspr-/-/caspr2-/-), immunostaining, comparison with single mutants","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — double KO genetic epistasis, defined cellular phenotype","pmids":["25378149"],"is_preprint":false},{"year":2011,"finding":"Cntnap2 knockout mice show neuronal migration abnormalities, reduced number of cortical interneurons, and abnormal neuronal network activity prior to seizure onset, establishing a functional role for CNTNAP2 in brain development including interneuron positioning.","method":"Cntnap2-/- knockout mouse characterization; neuropathological analysis, EEG recording, behavioral testing","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — clean KO with multiple defined cellular and circuit phenotypes, highly cited foundational study","pmids":["21962519"],"is_preprint":false},{"year":2012,"finding":"Autism-associated CNTNAP2 missense variants cause aberrant protein trafficking; the D1129H mutant is retained in the endoplasmic reticulum through interaction with ER chaperones (BiP/Grp78, Calnexin, ERp57) and activates the ATF6 branch of the unfolded protein response and proteasomal degradation; the 1253* frameshift mutation produces a secreted soluble protein lacking membrane anchorage.","method":"Immunofluorescence confocal microscopy and biochemical analysis in HEK-293 cells and hippocampal neurons; co-immunoprecipitation with ER chaperones; UPR pathway analysis","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis with multiple orthogonal biochemical methods, functional consequence demonstrated","pmids":["22872700"],"is_preprint":false},{"year":2016,"finding":"The ectodomain of CNTNAP2 consists of three lobes (large, medium, small) with distinct domain assignments, and binds directly and specifically to contactin 2 (CNTN2) with low nanomolar affinity; autism-associated mutations are distributed throughout the entire ectodomain rather than clustering in a single region.","method":"Electron microscopy of CNTNAP2 protein with epitope labeling, domain fragment analysis, direct binding assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — structural EM and quantitative binding assay with mutagenesis context","pmids":["27621318"],"is_preprint":false},{"year":2015,"finding":"CNTNAP2 plays a dose-dependent role in axon growth; loss of one Cntnap2 allele is sufficient to reduce axonal growth in cortical neurons; ASD missense variants I869T and G731S (with impaired TAG-1/Contactin2 binding) do not rescue axonal growth deficits; R1119H (which causes ER retention) has a dominant-negative effect via oligomerization with wild-type Caspr2; N407S also exerts a dominant-negative effect on axon growth despite normal membrane localization.","method":"Cortical neuron cultures from mouse embryos; heterozygous genetic background rescue assays; ASD missense variant functional analysis","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1 — in vitro functional rescue assays with multiple ASD variants, dominant-negative mechanism demonstrated by oligomerization","pmids":["29788201"],"is_preprint":false},{"year":2018,"finding":"Caspr2 autoantibodies inhibit the interaction of Caspr2 with contactin-2 (nanomolar affinity interaction confirmed by solid-phase binding assay) but do not cause internalization of surface Caspr2 in hippocampal neurons or transfected HEK cells; functional blocking of this cell adhesion molecule interaction is proposed as the pathogenic mechanism of IgG4 autoantibodies.","method":"Solid-phase binding assay, cell-based assay, cell-surface biotinylation, Western blot, live neuron cultures","journal":"Annals of neurology","confidence":"High","confidence_rationale":"Tier 1 — in vitro binding reconstitution with quantitative affinity measurement, multiple cell systems tested","pmids":["29244234"],"is_preprint":false},{"year":2018,"finding":"Either immune- or genetic-mediated loss of CASPR2 enhances primary afferent excitability through regulation of Kv1 channel expression at the DRG soma membrane; passive transfer of patient CASPR2 autoantibodies into mice causes mechanical pain hypersensitivity in a peripherally restricted manner without neural injury; Cntnap2-/- mice show increased DRG neuron excitability and enhanced nociceptive transmission in dorsal horn.","method":"Passive transfer of human autoantibodies into mice; Cntnap2-/- KO mice; in vivo and ex vivo electrophysiology; Kv1 channel quantification","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 1–2 — passive transfer model plus KO mice, electrophysiological mechanistic readouts, mechanistic convergence","pmids":["29429934"],"is_preprint":false},{"year":2019,"finding":"Caspr2 is expressed at excitatory synapses in the cortex; knockdown of Caspr2 in vitro or in vivo decreases synaptic expression of AMPA receptors and amplitude of AMPA receptor-mediated currents, and blocks both synaptic scaling in vitro and experience-dependent homeostatic synaptic plasticity in visual cortex; patient CASPR2 antibodies decrease dendritic Caspr2 levels and synaptic AMPA receptor trafficking.","method":"In vitro siRNA knockdown; in vivo knockdown; whole-cell electrophysiology; AMPA receptor trafficking assays; patient antibody treatment of neurons","journal":"Cerebral cortex","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (KD in vitro and in vivo, electrophysiology, antibody treatment), mechanistic pathway defined","pmids":["30843029"],"is_preprint":false},{"year":2015,"finding":"New dendritic spines in Cntnap2-/- mice are formed at normal rates but fail to stabilize, while rates of spine elimination are unaltered, revealing a specific role for CNTNAP2 in stabilizing new synaptic contacts in vivo.","method":"In vivo two-photon spine imaging in Cntnap2-/- knockout mice","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — clean KO with defined cellular phenotype, single lab","pmids":["25951243"],"is_preprint":false},{"year":2015,"finding":"Cntnap2-/- mice show selective reduction in perisomatic (but not dendritic) evoked IPSCs onto CA1 pyramidal cells, with normal excitatory transmission and normal miniature IPSC frequency and amplitude but increased spontaneous action potential-driven IPSCs, indicating Cntnap2 deletion selectively impairs perisomatic hippocampal inhibition.","method":"Whole-cell electrophysiology in acute hippocampal slices from Cntnap2-/- mice","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — clean KO with defined electrophysiological phenotype, single lab","pmids":["26511255"],"is_preprint":false},{"year":2019,"finding":"Cntnap2 knockout mice show a dramatic decrease in excitatory and inhibitory synaptic inputs onto L2/3 pyramidal neurons of the medial prefrontal cortex, with reduced spines and synapses, increased activity in inhibitory neurons in vivo, and reduced phase-locking to delta and theta oscillations despite normal dendritic complexity and intrinsic excitability.","method":"Laser-scanning photostimulation, whole-cell recordings, electron microscopy, in vivo local field potential and unit recording","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods (in vitro and in vivo electrophysiology, EM), mechanistic circuit phenotype defined","pmids":["31141683"],"is_preprint":false},{"year":2019,"finding":"Loss of Cntnap2 causes profound deficiency in clustering of Kv1-family potassium channels at juxtaparanodes of brain myelinated axons, alters axonal action potential waveform, increases postsynaptic excitatory responses, and delays the normal process of cortical myelination.","method":"Cntnap2-/- mouse electrophysiology, immunostaining of myelinated axons, developmental myelination analysis","journal":"Cerebral cortex","confidence":"High","confidence_rationale":"Tier 2 — KO mice with electrophysiological and anatomical mechanistic readouts, multiple parameters assessed","pmids":["29300891"],"is_preprint":false},{"year":2018,"finding":"Cntnap2 cell-autonomously regulates the physiology of parvalbumin (PV)+, fast-spiking cortical interneurons; human ASD missense mutations in CNTNAP2 impair PV+ interneuron development; somatostatin+ regular-spiking interneurons are not affected.","method":"Transplantation assay of MGE-derived interneurons into wild-type brain; constitutive Cntnap2 null mice; in vivo testing of human ASD missense alleles","journal":"Cerebral cortex","confidence":"High","confidence_rationale":"Tier 2 — cell-autonomous demonstration via transplantation assay, multiple human variants tested","pmids":["29028946"],"is_preprint":false},{"year":2015,"finding":"Interaction proteomics reveals the Caspr2 interactome includes CNTN2, Kv1 channels (KCNAs), ADAM family members (ADAM22, ADAM23, ADAM11), LGI family members, and MAGUKs (DLGs, MPPs); a short isoform of Caspr2 lacking most extracellular domains still associates with ADAM22, LGI1, and Kv1 channels; Caspr2 is enriched in lipid rafts and synaptic membrane but depleted from the postsynaptic density.","method":"Co-immunoprecipitation/interaction proteomics; subcellular fractionation; Western blot","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 — mass spectrometry-based interactome, single lab","pmids":["25707359"],"is_preprint":false},{"year":2015,"finding":"CASPR2 forms a tripartite complex with GPR37 and MUPP1 in the mouse brain; CASPR2 interacts with the PDZ3 domain of MUPP1, and GPR37 interacts with the PDZ11 domain; the ASD-related GPR37(R558Q) mutation impairs binding to MUPP1 and prevents cell-surface transport by MUPP1, causing ER retention and loss of synaptic co-localization with CASPR2 and MUPP1 in hippocampal neurons.","method":"Co-immunoprecipitation from mouse brain; cell-based assay; immunofluorescence in primary hippocampal neurons; domain-deletion and point-mutation analysis","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP from brain plus cell-based functional assay, single lab","pmids":["25977097"],"is_preprint":false},{"year":2019,"finding":"Cntnap2-/- mice show hyperactive Akt-mTOR signaling in the hippocampus; treatment with Akt inhibitor LY294002 or mTOR inhibitor rapamycin rescues social deficits (but not hyperactivity or repetitive behaviors) in Cntnap2-/- mice, identifying dysregulated Akt-mTOR as a pathway downstream of CNTNAP2 loss.","method":"RNA sequencing, biochemical pathway analysis, pharmacological rescue in Cntnap2-/- mice","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — pathway identified by transcriptomics and confirmed by pharmacological rescue, single lab","pmids":["30816216"],"is_preprint":false},{"year":2023,"finding":"CNTNAP2 is cleaved by γ-secretase to produce a CNTNAP2 intracellular domain (CICD); CICD promotes nuclear translocation of CASK to regulate transcription of Necdin; viral delivery of CICD to the mPFC of Cntnap2-/- mice rescues social and repetitive behavior deficits; Necdin deficiency reduces social interaction, and viral Necdin expression in mPFC rescues social preference in Cntnap2-/- mice, defining a CNTNAP2-CASK-Necdin signaling pathway.","method":"Biochemical γ-secretase cleavage assay; viral CICD delivery; nuclear translocation assays; behavioral rescue; Necdin rescue in mPFC","journal":"Signal transduction and targeted therapy","confidence":"Medium","confidence_rationale":"Tier 1–2 — biochemical cleavage assay, in vivo viral rescue, pathway mechanistically defined, single lab","pmids":["37271769"],"is_preprint":false},{"year":2012,"finding":"STOX1A, a forkhead-related transcription factor, directly downregulates CNTNAP2 as identified by chromatin immunoprecipitation coupled to shotgun cloning.","method":"Chromatin immunoprecipitation (ChIP) with shotgun cloning; gene expression analysis","journal":"Journal of Alzheimer's disease","confidence":"Low","confidence_rationale":"Tier 3 — single ChIP experiment, single lab, limited mechanistic follow-up","pmids":["22728895"],"is_preprint":false},{"year":2017,"finding":"Experimental downregulation of FoxP2 in zebra finch Area X using lentiviral vectors reduces Cntnap2 expression; FoxP2 binds to and activates the avian CNTNAP2 promoter in vitro; natural downregulation of FoxP2 by age or singing also downregulates Cntnap2, establishing CNTNAP2 as a direct transcriptional target of FOXP2.","method":"Lentiviral FoxP2 knockdown in vivo; luciferase promoter assay in vitro; in situ hybridization; qPCR","journal":"Genes, brain, and behavior","confidence":"Medium","confidence_rationale":"Tier 1–2 — in vitro promoter assay plus in vivo knockdown, ortholog context (songbird), multiple methods","pmids":["28488276"],"is_preprint":false},{"year":2022,"finding":"Infusion of patients' IgG (anti-CASPR2 encephalitis) into mouse cerebroventricles causes memory impairment, reduces surface CASPR2 clusters, decreases CASPR2/TAG-1 co-localization (demonstrated by STED super-resolution microscopy), and lowers hippocampal Kv1.1 and GluA1 levels; in cultured neurons, patients' IgG selectively internalizes CASPR2 without affecting TAG-1; all effects are reversible upon IgG removal.","method":"Intracerebroventricular IgG infusion mouse model; STED super-resolution microscopy; confocal quantification of Kv1.1 and GluA1; behavioral tests; cultured neuron internalization assay","journal":"Annals of neurology","confidence":"High","confidence_rationale":"Tier 1–2 — in vivo passive transfer with super-resolution structural validation, multiple functional readouts, reversibility demonstrated","pmids":["35253937"],"is_preprint":false},{"year":2016,"finding":"In cultured hippocampal neurons, the LNG2-EGF1 modules in the Caspr2 ectodomain and the cytoplasmic PDZ-binding site regulate axonal positioning; deletion of LNG2-EGF1 promotes AIS localization and association with TAG-1; the PDZ-binding site can elicit AIS enrichment and recruit MPP2; Caspr2 and TAG-1 are co-sorted in axonal transport vesicles.","method":"Live-cell imaging; deletion construct analysis; co-transport vesicle imaging in hippocampal neurons","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 — domain-deletion mutagenesis combined with live-cell imaging, single lab","pmids":["28533267"],"is_preprint":false},{"year":2015,"finding":"Caspr2 autoantibodies from limbic encephalitis patients are directed against the N-terminal Discoidin and LamininG1 modules; in live hippocampal neuron cultures, these antibodies selectively target inhibitory interneurons (GAD65-positive axons and VGAT-positive presynaptic contacts), and may induce alteration of Gephyrin clusters at inhibitory synapses; Caspr2-Fc chimera binding to hippocampal neurons requires TAG-1 as a receptor.","method":"Domain-deletion mapping; live immunolabeling of hippocampal neurons; Caspr2-Fc chimera binding assay; comparison with TAG-1-deficient mouse neurons","journal":"Frontiers in cellular neuroscience","confidence":"Medium","confidence_rationale":"Tier 2–3 — domain mapping plus functional cell-based assay, single lab","pmids":["26217189"],"is_preprint":false},{"year":2016,"finding":"Assembly of juxtaparanodal Kv1/Caspr2 complex during myelination requires protein 4.1B: in 4.1B KO myelinating DRG cultures and sciatic nerves, Caspr2 fails to be properly targeted early during myelination; Caspr2 and Kv1 channels transiently accumulate at the nodal region before relocalizing to juxtaparanodes; Kv1 channels display asymmetric enrichment at distal juxtaparanodes.","method":"Myelinating DRG/Schwann cell co-cultures; 4.1B KO mice; photobleaching (FRAP) of paranodal Caspr; adenoviral Caspr-GFP expression","journal":"Glia","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse plus in vitro myelinating cultures, FRAP analysis, single lab","pmids":["26840208"],"is_preprint":false},{"year":2017,"finding":"Disorganization of axonal domains in Caspr2 single mutants (and Caspr1/Caspr2 double mutants) in peripheral myelinated axons disrupts neuromuscular junction integrity, leading to NMJ denervation, reduced postsynaptic endplate areas, and muscle fiber degeneration with mitochondrial dysfunction in double mutants.","method":"Single and double Caspr1/Caspr2 knockout mice; NMJ immunostaining; muscle histology; electron microscopy","journal":"Journal of neuroscience research","confidence":"Medium","confidence_rationale":"Tier 2 — double KO genetic epistasis, defined cellular and tissue phenotype, single lab","pmids":["28370195"],"is_preprint":false},{"year":2015,"finding":"Cntnap2 is expressed in all primary sensory organs and in distinct brain regions involved in different sensory modalities; Cntnap2-/- mice exhibit abnormal sensory responses, including lack of preference for novel odors in olfaction-based tasks, linking Caspr2 loss throughout the sensory system to sensory manifestations.","method":"Caspr2:tau-LacZ knock-in reporter mouse; behavioral olfactory testing of Cntnap2-/- mice","journal":"Molecular and cellular neurosciences","confidence":"Medium","confidence_rationale":"Tier 2 — knock-in reporter plus KO behavioral phenotype, single lab","pmids":["26647347"],"is_preprint":false},{"year":2015,"finding":"Cntnap2-/- mice exhibit a decrease in oxytocin immunoreactive neurons in the paraventricular nucleus of the hypothalamus and overall decreased brain oxytocin levels; acute oxytocin administration or activation of endogenous oxytocin neurons via DREADD rescues social deficits; chronic early postnatal oxytocin treatment leads to more lasting behavioral recovery and restores oxytocin immunoreactivity in the PVN.","method":"Oxytocin immunostaining, ELISA for brain oxytocin; pharmacological rescue; DREADD-based chemogenetic activation of PVN oxytocin neurons in Cntnap2-/- mice","journal":"Science translational medicine","confidence":"High","confidence_rationale":"Tier 2 — multiple methods (immunostaining, ELISA, pharmacology, chemogenetics), functional pathway defined in KO mice","pmids":["25609168"],"is_preprint":false},{"year":2021,"finding":"Patient-derived forebrain organoids with homozygous CNTNAP2 protein-truncating mutation display increased volume and cell number driven by increased neural progenitor proliferation; PFC-excitatory neurons are the key CNTNAP2-expressing cell type; organoid overgrowth phenotype is rescued by CRISPR-Cas9 correction of the mutation.","method":"iPSC-derived forebrain organoids; single-cell RNA sequencing; CRISPR-Cas9 correction; cell proliferation assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 — isogenic CRISPR correction, single-cell transcriptomics, functional rescue, multiple orthogonal methods","pmids":["34471112"],"is_preprint":false}],"current_model":"CNTNAP2/Caspr2 is a large multidomain neurexin-family transmembrane cell adhesion molecule that: (1) forms a complex with TAG-1 (contactin-2) at the axonal juxtaparanodal region to cluster Kv1 potassium channels, requiring its cytoplasmic domain's interaction with protein 4.1B for membrane localization; (2) undergoes PKC-dependent somatodendritic endocytosis to achieve polarized axonal surface expression; (3) is transcriptionally regulated by FOXP2; (4) is cleaved by γ-secretase to release an intracellular domain (CICD) that translocates CASK to the nucleus to drive Necdin transcription, thereby regulating social behavior; (5) is required for normal cortical interneuron (especially PV+) development, dendritic spine stabilization, AMPA receptor synaptic expression and homeostatic plasticity, and cortical myelination; and (6) when absent causes hyperactive Akt-mTOR signaling and dysregulated oxytocin neuron function, while autoantibodies targeting its extracellular domain block its interaction with contactin-2 and trigger internalization of CASPR2 with downstream loss of Kv1 channels and AMPA receptors, causing encephalitis and neuropathic pain."},"narrative":{"teleology":[{"year":2001,"claim":"Before Caspr2's function was known at the node of Ranvier, analysis of paranodal adhesion mutants established that the juxtaparanodal positioning of Caspr2 and Kv1.2 depends on intact paranodal barriers, revealing that axon-glia interactions gate Caspr2 localization.","evidence":"Immunostaining in CGT-/- and contactin-KO mice with developmental time-course","pmids":["11567047"],"confidence":"High","gaps":["Mechanism by which paranodal barriers exclude Caspr2 not defined","Whether Caspr2 is actively transported or passively excluded was unknown"]},{"year":2003,"claim":"Gene-targeted deletion of Caspr2 established it as the essential organizer for juxtaparanodal Kv1 channel clustering and demonstrated that this function requires the Caspr2–TAG-1 interaction, defining the core adhesion complex at the juxtaparanode.","evidence":"Cntnap2 knockout mice with immunostaining and co-localization studies","pmids":["12963709"],"confidence":"High","gaps":["Which Caspr2 domains mediate Kv1 recruitment was unknown","Trans vs. cis interaction with TAG-1 not resolved"]},{"year":2008,"claim":"Transgenic rescue with domain-deletion mutants resolved that the Caspr2 cytoplasmic domain (not the PDZ-binding motif) is essential for Kv1 clustering, and that PSD-93/PSD-95 accumulate at juxtaparanodes in a Caspr2-dependent manner, while PSD-93 independently clusters Kv1 at the AIS.","evidence":"Caspr2-null mice rescued with Caspr2ΔCT or Caspr2ΔPDZ transgenes; PSD-93 KO and RNAi","pmids":["19109503","18509034"],"confidence":"High","gaps":["Precise scaffolding contacts between Caspr2 cytoplasmic domain and Kv1 subunits not identified","Role of individual MAGUK family members at juxtaparanode not dissected"]},{"year":2009,"claim":"The mechanism of Caspr2 axonal polarization was revealed to be selective somatodendritic endocytosis rather than directed axonal transport, requiring dynamin and a PKC-phosphorylatable residue (Thr1292) within the 4.1B-binding domain.","evidence":"HA-tagged Caspr2 in hippocampal neurons with dominant-negative dynamin, Dynasore, T1292 mutagenesis, and live-cell imaging","pmids":["19706678"],"confidence":"High","gaps":["Identity of the PKC isoform phosphorylating T1292 not determined","Whether this mechanism operates in vivo during myelination not shown"]},{"year":2010,"claim":"The requirement for protein 4.1B in Caspr2 membrane retention was demonstrated: a Caspr2 transgene lacking the 4.1B-binding sequence and 4.1B-null mice both fail to accumulate Caspr2 and Kv1 at juxtaparanodes, establishing 4.1B as a critical cytoskeletal anchor.","evidence":"Transgenic rescue with Caspr2-Δ4.1 in Caspr2-null mice; 4.1B-null mice","pmids":["20164332"],"confidence":"High","gaps":["Whether 4.1B links Caspr2 to spectrin-actin cytoskeleton directly or through intermediaries not resolved","Redundancy with other 4.1 family members not fully tested"]},{"year":2011,"claim":"Beyond its role at axonal domains, Cntnap2 knockout mice revealed a developmental function: reduced cortical interneurons, neuronal migration abnormalities, and abnormal network activity prior to seizure onset, establishing Caspr2 as a regulator of cortical circuit assembly.","evidence":"Cntnap2-/- mice with neuropathological analysis, EEG, behavioral testing","pmids":["21962519"],"confidence":"High","gaps":["Cell-autonomous vs. non-autonomous mechanism of interneuron loss not determined at this stage","Molecular pathway linking Caspr2 to migration not identified"]},{"year":2012,"claim":"Autism-associated CNTNAP2 missense variants were shown to cause pathology through protein misfolding: D1129H is retained in the ER via chaperone interactions and activates the ATF6 UPR branch, while the 1253* frameshift produces a secreted, untethered protein, revealing loss-of-function mechanisms at the protein level.","evidence":"Confocal microscopy and co-immunoprecipitation in HEK-293 cells and hippocampal neurons","pmids":["22872700"],"confidence":"High","gaps":["Whether ER-retained variants exert gain-of-function toxicity via chronic UPR activation not tested in vivo","Prevalence of trafficking-defective variants among all ASD-associated CNTNAP2 alleles unknown"]},{"year":2015,"claim":"Multiple studies converged to define Caspr2's synaptic and circuit-level roles: it stabilizes new dendritic spines, selectively supports perisomatic inhibition, and its interactome includes ADAM22/23, LGI family, Kv1 channels, and MAGUKs; separately, loss of Cntnap2 causes reduced hypothalamic oxytocin neurons and brain oxytocin, with oxytocin administration rescuing social deficits.","evidence":"In vivo two-photon spine imaging; hippocampal slice electrophysiology; interaction proteomics/co-IP; oxytocin immunostaining, ELISA, DREADD chemogenetics in Cntnap2-/- mice","pmids":["25951243","26511255","25707359","25609168"],"confidence":"High","gaps":["How Caspr2 mechanistically stabilizes spines (signaling pathway) unknown","Whether oxytocin deficit is cell-autonomous or circuit-level consequence not resolved","Functional significance of ADAM22/LGI1 interaction for Caspr2 not tested"]},{"year":2015,"claim":"ASD-associated CNTNAP2 missense variants I869T and G731S (impaired TAG-1 binding) fail to rescue axon growth in haploinsufficient neurons, while R1119H exerts a dominant-negative effect through oligomerization with wild-type Caspr2, demonstrating dose-dependent and dominant-negative pathogenic mechanisms.","evidence":"Cortical neuron cultures from heterozygous Cntnap2+/- mouse embryos with variant rescue assays","pmids":["29788201"],"confidence":"High","gaps":["Oligomerization interface enabling dominant-negative effect not structurally defined","In vivo consequences of heterozygous ASD variants not characterized"]},{"year":2016,"claim":"Structural characterization of the Caspr2 ectodomain by EM revealed a three-lobed architecture that binds contactin-2 with low-nanomolar affinity; autism-associated mutations are distributed throughout the ectodomain rather than clustering in one binding interface.","evidence":"Electron microscopy with epitope labeling; domain fragment binding assays","pmids":["27621318"],"confidence":"High","gaps":["Atomic-resolution structure not available","Which ectodomain surface contacts contactin-2 not mapped"]},{"year":2018,"claim":"Caspr2 was shown to cell-autonomously regulate PV+ fast-spiking interneuron physiology but not somatostatin+ interneurons, and separately, passive transfer of patient CASPR2 autoantibodies into mice demonstrated that immune-mediated Caspr2 loss enhances DRG excitability and causes neuropathic pain through peripheral Kv1 channel dysregulation.","evidence":"MGE-derived interneuron transplantation into wild-type brain; passive transfer of patient IgG; Cntnap2-/- DRG electrophysiology","pmids":["29028946","29429934"],"confidence":"High","gaps":["How Caspr2 controls PV+ interneuron maturation at the molecular level unknown","Whether peripheral and central autoantibody effects are mechanistically distinct not resolved"]},{"year":2018,"claim":"Caspr2 autoantibodies were shown to block the Caspr2–contactin-2 interaction at nanomolar sensitivity, identifying functional disruption of this adhesion complex as the primary pathogenic mechanism of IgG4 autoantibodies in encephalitis.","evidence":"Solid-phase binding assay; cell-surface biotinylation in hippocampal neurons and HEK cells","pmids":["29244234"],"confidence":"High","gaps":["Whether different epitope specificities of patient antibodies produce different clinical phenotypes not tested","Complement-independent vs. complement-dependent pathology not dissected"]},{"year":2019,"claim":"Caspr2's synaptic role was extended to excitatory synapses: knockdown reduces synaptic AMPA receptor expression and blocks homeostatic synaptic scaling both in vitro and in visual cortex in vivo; patient antibodies phenocopy this by internalizing dendritic Caspr2 and reducing AMPA receptor trafficking.","evidence":"siRNA knockdown in vitro and in vivo; whole-cell electrophysiology; AMPA receptor trafficking assays; patient antibody treatment","pmids":["30843029"],"confidence":"High","gaps":["Molecular mechanism linking Caspr2 to AMPA receptor insertion/retention unknown","Whether Caspr2-dependent homeostatic plasticity operates at all cortical synapses or is layer-specific not determined"]},{"year":2019,"claim":"Loss of Cntnap2 profoundly reduces both excitatory and inhibitory synaptic inputs onto mPFC L2/3 pyramidal neurons despite normal dendritic morphology and intrinsic excitability, and disrupts cortical myelination timing and axonal action potential waveform, revealing convergent circuit-level consequences.","evidence":"Laser-scanning photostimulation, in vivo electrophysiology, EM in Cntnap2-/- mice; developmental myelination analysis","pmids":["31141683","29300891"],"confidence":"High","gaps":["Whether myelination delay is secondary to altered neuronal activity or a direct glial effect of Caspr2 loss unknown","Relationship between mPFC circuit changes and behavioral phenotypes not causally tested"]},{"year":2021,"claim":"Patient-derived forebrain organoids with homozygous CNTNAP2 truncation revealed increased neural progenitor proliferation and organoid overgrowth, rescued by CRISPR correction, identifying a human-relevant role for CNTNAP2 in controlling progenitor expansion in PFC-excitatory neuron lineages.","evidence":"iPSC-derived forebrain organoids; scRNA-seq; CRISPR-Cas9 isogenic correction","pmids":["34471112"],"confidence":"High","gaps":["Signaling pathway by which Caspr2 restrains progenitor proliferation not identified","Whether this phenotype occurs in heterozygous patient cells not tested"]},{"year":2022,"claim":"In vivo infusion of patient anti-CASPR2 IgG confirmed a unified autoimmune mechanism: antibodies internalize surface Caspr2, disrupt Caspr2/TAG-1 co-localization (by STED), and reduce both Kv1.1 and GluA1, with full reversibility upon IgG removal, establishing the downstream molecular cascade of autoantibody-mediated encephalitis.","evidence":"Intracerebroventricular IgG infusion; STED super-resolution microscopy; behavioral testing; cultured neuron internalization assay","pmids":["35253937"],"confidence":"High","gaps":["Whether antibody-induced internalization proceeds via the same PKC/dynamin pathway as physiological somatodendritic endocytosis unknown","Long-term irreversible synaptic damage thresholds not defined"]},{"year":2023,"claim":"A non-canonical signaling function was discovered: γ-secretase cleavage of Caspr2 releases an intracellular domain (CICD) that translocates CASK to the nucleus to activate Necdin transcription, with viral CICD or Necdin delivery to mPFC rescuing social deficits in Cntnap2-/- mice.","evidence":"Biochemical γ-secretase cleavage assay; viral CICD and Necdin rescue in mPFC of Cntnap2-/- mice; nuclear translocation assays","pmids":["37271769"],"confidence":"Medium","gaps":["γ-secretase cleavage regulation and stimulus-dependence not characterized","Independent replication of CICD nuclear signaling pathway needed","Whether CICD signaling operates at juxtaparanodes or only at synapses unknown"]},{"year":null,"claim":"Key unresolved questions include the atomic-resolution structure of the Caspr2–contactin-2 complex, the signaling pathway by which Caspr2 controls neural progenitor proliferation and interneuron migration, the precise mechanism linking Caspr2 to AMPA receptor synaptic retention, and whether the γ-secretase/CICD/CASK/Necdin pathway is broadly operative across brain regions.","evidence":"","pmids":[],"confidence":"High","gaps":["No atomic-resolution structure of Caspr2 or Caspr2–CNTN2 complex","Signaling cascade from Caspr2 to progenitor proliferation control not identified","Mechanism of AMPA receptor stabilization by Caspr2 at the molecular level unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098631","term_label":"cell adhesion mediator activity","supporting_discovery_ids":[0,9,11]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[2,4,19]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,1,5,26]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[22]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[8]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,2,7,13,15,17]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[21,22]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[7,18,32]},{"term_id":"R-HSA-1500931","term_label":"Cell-Cell communication","supporting_discovery_ids":[0,9,11]}],"complexes":["Caspr2/TAG-1(CNTN2)/Kv1 juxtaparanodal complex","Caspr2/ADAM22/LGI1 complex","Caspr2/GPR37/MUPP1 complex"],"partners":["CNTN2","EPB41L3","ADAM22","LGI1","CASK","DLG1","MPP2","MPDZ"],"other_free_text":[]},"mechanistic_narrative":"CNTNAP2 (Caspr2) is a neurexin-superfamily transmembrane cell adhesion molecule that organizes axonal domains, regulates synaptic function, and controls cortical development. At myelinated axons, Caspr2 forms a complex with contactin-2/TAG-1 and, through its cytoplasmic protein 4.1B-binding domain, clusters Kv1 potassium channels at the juxtaparanodal region, thereby shaping axonal excitability and action potential waveform [PMID:12963709, PMID:20164332, PMID:29300891]. At excitatory synapses, Caspr2 stabilizes newly formed dendritic spines, maintains synaptic AMPA receptor expression, and is required for homeostatic synaptic scaling; its intracellular domain, released by γ-secretase cleavage, translocates CASK to the nucleus to drive Necdin transcription and regulate social behavior [PMID:30843029, PMID:25951243, PMID:37271769]. Loss of CNTNAP2 causes reduced cortical interneurons (particularly parvalbumin-positive), neuronal migration abnormalities, hyperactive Akt-mTOR signaling, decreased hypothalamic oxytocin, and increased neural progenitor proliferation, while patient autoantibodies against the Caspr2 ectodomain internalize surface Caspr2, disrupt contactin-2 binding, and reduce Kv1 channels and GluA1, causing autoimmune encephalitis and neuropathic pain [PMID:21962519, PMID:29028946, PMID:35253937, PMID:29429934]."},"prefetch_data":{"uniprot":{"accession":"Q9UHC6","full_name":"Contactin-associated protein-like 2","aliases":["Cell recognition molecule Caspr2"],"length_aa":1331,"mass_kda":148.2,"function":"Required for gap junction formation (Probable). Required, with CNTNAP1, for radial and longitudinal organization of myelinated axons. Plays a role in the formation of functional distinct domains critical for saltatory conduction of nerve impulses in myelinated nerve fibers. Demarcates the juxtaparanodal region of the axo-glial junction","subcellular_location":"Membrane; Cell projection, axon; Cell junction, paranodal septate junction","url":"https://www.uniprot.org/uniprotkb/Q9UHC6/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CNTNAP2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CNTNAP2","total_profiled":1310},"omim":[{"mim_id":"614325","title":"PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2","url":"https://www.omim.org/entry/614325"},{"mim_id":"613272","title":"POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 3; KCTD3","url":"https://www.omim.org/entry/613272"},{"mim_id":"612514","title":"SPECIFIC LANGUAGE IMPAIRMENT 4; SLI4","url":"https://www.omim.org/entry/612514"},{"mim_id":"612100","title":"AUTISM, SUSCEPTIBILITY TO, 15; AUTS15","url":"https://www.omim.org/entry/612100"},{"mim_id":"610954","title":"PITT-HOPKINS SYNDROME; PTHS","url":"https://www.omim.org/entry/610954"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":34.8},{"tissue":"retina","ntpm":13.4}],"url":"https://www.proteinatlas.org/search/CNTNAP2"},"hgnc":{"alias_symbol":["Caspr2","KIAA0868","NRXN4"],"prev_symbol":[]},"alphafold":{"accession":"Q9UHC6","domains":[{"cath_id":"2.60.120.260","chopping":"38-183","consensus_level":"high","plddt":95.1428,"start":38,"end":183},{"cath_id":"2.60.120.200","chopping":"188-354","consensus_level":"high","plddt":88.7954,"start":188,"end":354},{"cath_id":"2.60.120.200","chopping":"377-505_514-550","consensus_level":"high","plddt":90.7211,"start":377,"end":550},{"cath_id":"2.60.120.1000","chopping":"636-796","consensus_level":"high","plddt":89.8161,"start":636,"end":796},{"cath_id":"2.60.120.200","chopping":"800-964","consensus_level":"high","plddt":89.3981,"start":800,"end":964},{"cath_id":"2.10.25.10","chopping":"968-1001","consensus_level":"medium","plddt":81.4271,"start":968,"end":1001},{"cath_id":"2.60.120.200","chopping":"1006-1021_1046-1212","consensus_level":"high","plddt":90.0748,"start":1006,"end":1212}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UHC6","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UHC6-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UHC6-F1-predicted_aligned_error_v6.png","plddt_mean":83.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CNTNAP2","jax_strain_url":"https://www.jax.org/strain/search?query=CNTNAP2"},"sequence":{"accession":"Q9UHC6","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UHC6.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UHC6/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UHC6"}},"corpus_meta":[{"pmid":"21962519","id":"PMC_21962519","title":"Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits.","date":"2011","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/21962519","citation_count":852,"is_preprint":false},{"pmid":"12963709","id":"PMC_12963709","title":"Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1.","date":"2003","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12963709","citation_count":467,"is_preprint":false},{"pmid":"21387375","id":"PMC_21387375","title":"Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia.","date":"2011","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/21387375","citation_count":331,"is_preprint":false},{"pmid":"27371488","id":"PMC_27371488","title":"The clinical spectrum of Caspr2 antibody-associated disease.","date":"2016","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/27371488","citation_count":312,"is_preprint":false},{"pmid":"25609168","id":"PMC_25609168","title":"Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism.","date":"2015","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25609168","citation_count":309,"is_preprint":false},{"pmid":"17646849","id":"PMC_17646849","title":"CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy.","date":"2007","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/17646849","citation_count":233,"is_preprint":false},{"pmid":"23714751","id":"PMC_23714751","title":"Shining a light on CNTNAP2: complex functions to complex disorders.","date":"2013","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/23714751","citation_count":205,"is_preprint":false},{"pmid":"26833134","id":"PMC_26833134","title":"Estrogens Suppress a Behavioral Phenotype in Zebrafish Mutants of the Autism Risk Gene, CNTNAP2.","date":"2016","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/26833134","citation_count":158,"is_preprint":false},{"pmid":"29055902","id":"PMC_29055902","title":"LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes.","date":"2017","source":"Journal of neurology, neurosurgery, and psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/29055902","citation_count":156,"is_preprint":false},{"pmid":"23407760","id":"PMC_23407760","title":"Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping.","date":"2013","source":"JAMA neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23407760","citation_count":148,"is_preprint":false},{"pmid":"29429934","id":"PMC_29429934","title":"Immune or Genetic-Mediated Disruption of CASPR2 Causes Pain Hypersensitivity Due to Enhanced Primary Afferent Excitability.","date":"2018","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/29429934","citation_count":144,"is_preprint":false},{"pmid":"22365836","id":"PMC_22365836","title":"What does CNTNAP2 reveal about autism spectrum disorder?","date":"2012","source":"Trends in molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22365836","citation_count":135,"is_preprint":false},{"pmid":"29788256","id":"PMC_29788256","title":"Distinct HLA associations of LGI1 and CASPR2-antibody diseases.","date":"2018","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/29788256","citation_count":127,"is_preprint":false},{"pmid":"31782181","id":"PMC_31782181","title":"Randomized Placebo-Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy.","date":"2019","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/31782181","citation_count":120,"is_preprint":false},{"pmid":"11567047","id":"PMC_11567047","title":"Localization of Caspr2 in myelinated nerves depends on axon-glia interactions and the generation of barriers along the axon.","date":"2001","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11567047","citation_count":113,"is_preprint":false},{"pmid":"18509034","id":"PMC_18509034","title":"Postsynaptic density-93 clusters Kv1 channels at axon initial segments independently of Caspr2.","date":"2008","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18509034","citation_count":112,"is_preprint":false},{"pmid":"21827697","id":"PMC_21827697","title":"Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1.","date":"2011","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21827697","citation_count":100,"is_preprint":false},{"pmid":"19582487","id":"PMC_19582487","title":"Disruption of CNTNAP2 and additional structural genome changes in a boy with speech delay and autism spectrum disorder.","date":"2009","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/19582487","citation_count":100,"is_preprint":false},{"pmid":"19109503","id":"PMC_19109503","title":"Multiple molecular interactions determine the clustering of Caspr2 and Kv1 channels in myelinated axons.","date":"2008","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19109503","citation_count":98,"is_preprint":false},{"pmid":"31141683","id":"PMC_31141683","title":"Reduced Prefrontal Synaptic Connectivity and Disturbed Oscillatory Population Dynamics in the CNTNAP2 Model of Autism.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31141683","citation_count":96,"is_preprint":false},{"pmid":"20164332","id":"PMC_20164332","title":"Organization of myelinated axons by Caspr and Caspr2 requires the cytoskeletal adapter protein 4.1B.","date":"2010","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20164332","citation_count":93,"is_preprint":false},{"pmid":"29244234","id":"PMC_29244234","title":"Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia.","date":"2018","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/29244234","citation_count":89,"is_preprint":false},{"pmid":"25852443","id":"PMC_25852443","title":"Connecting the CNTNAP2 Networks with Neurodevelopmental Disorders.","date":"2015","source":"Molecular syndromology","url":"https://pubmed.ncbi.nlm.nih.gov/25852443","citation_count":84,"is_preprint":false},{"pmid":"28184409","id":"PMC_28184409","title":"Homozygous Loss of Autism-Risk Gene CNTNAP2 Results in Reduced Local and Long-Range Prefrontal Functional Connectivity.","date":"2018","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/28184409","citation_count":82,"is_preprint":false},{"pmid":"34471112","id":"PMC_34471112","title":"Cortical overgrowth in a preclinical forebrain organoid model of CNTNAP2-associated autism spectrum disorder.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34471112","citation_count":80,"is_preprint":false},{"pmid":"31912210","id":"PMC_31912210","title":"Systematic review of the clinical spectrum of CASPR2 antibody syndrome.","date":"2020","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/31912210","citation_count":77,"is_preprint":false},{"pmid":"32651251","id":"PMC_32651251","title":"Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features.","date":"2020","source":"Journal of neurology, neurosurgery, and psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/32651251","citation_count":76,"is_preprint":false},{"pmid":"29028946","id":"PMC_29028946","title":"Mouse Cntnap2 and Human CNTNAP2 ASD Alleles Cell Autonomously Regulate PV+ Cortical Interneurons.","date":"2018","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/29028946","citation_count":75,"is_preprint":false},{"pmid":"25951243","id":"PMC_25951243","title":"The Autism Related Protein Contactin-Associated Protein-Like 2 (CNTNAP2) Stabilizes New Spines: An In Vivo Mouse Study.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25951243","citation_count":74,"is_preprint":false},{"pmid":"29300891","id":"PMC_29300891","title":"Loss of Cntnap2 Causes Axonal Excitability Deficits, Developmental Delay in Cortical Myelination, and Abnormal Stereotyped Motor Behavior.","date":"2019","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/29300891","citation_count":69,"is_preprint":false},{"pmid":"30116174","id":"PMC_30116174","title":"Dysregulation of Parvalbumin Expression in the Cntnap2-/- Mouse Model of Autism Spectrum Disorder.","date":"2018","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30116174","citation_count":66,"is_preprint":false},{"pmid":"26511255","id":"PMC_26511255","title":"Selective Dysregulation of Hippocampal Inhibition in the Mouse Lacking Autism Candidate Gene CNTNAP2.","date":"2015","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26511255","citation_count":63,"is_preprint":false},{"pmid":"28638854","id":"PMC_28638854","title":"Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis.","date":"2017","source":"Neurology(R) neuroimmunology & neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/28638854","citation_count":60,"is_preprint":false},{"pmid":"19706678","id":"PMC_19706678","title":"Axonal targeting of Caspr2 in hippocampal neurons via selective somatodendritic endocytosis.","date":"2009","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/19706678","citation_count":58,"is_preprint":false},{"pmid":"26647347","id":"PMC_26647347","title":"Expression of Cntnap2 (Caspr2) in multiple levels of sensory systems.","date":"2015","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/26647347","citation_count":56,"is_preprint":false},{"pmid":"23123147","id":"PMC_23123147","title":"CNTNAP2 is significantly associated with schizophrenia and major depression in the Han Chinese population.","date":"2012","source":"Psychiatry research","url":"https://pubmed.ncbi.nlm.nih.gov/23123147","citation_count":56,"is_preprint":false},{"pmid":"30816216","id":"PMC_30816216","title":"Suppression of Akt-mTOR pathway rescued the social behavior in Cntnap2-deficient mice.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30816216","citation_count":55,"is_preprint":false},{"pmid":"31630242","id":"PMC_31630242","title":"Daratumumab treatment for therapy-refractory anti-CASPR2 encephalitis.","date":"2019","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/31630242","citation_count":53,"is_preprint":false},{"pmid":"26217189","id":"PMC_26217189","title":"Inhibitory axons are targeted in hippocampal cell culture by anti-Caspr2 autoantibodies associated with limbic encephalitis.","date":"2015","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26217189","citation_count":53,"is_preprint":false},{"pmid":"28364455","id":"PMC_28364455","title":"Cntnap2 Knockout Rats and Mice Exhibit Epileptiform Activity and Abnormal Sleep-Wake Physiology.","date":"2017","source":"Sleep","url":"https://pubmed.ncbi.nlm.nih.gov/28364455","citation_count":52,"is_preprint":false},{"pmid":"32783406","id":"PMC_32783406","title":"Anti-LGI1, anti-GABABR, and Anti-CASPR2 encephalitides in Asia: A systematic review.","date":"2020","source":"Brain and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/32783406","citation_count":51,"is_preprint":false},{"pmid":"30843029","id":"PMC_30843029","title":"Disrupted AMPA Receptor Function upon Genetic- or Antibody-Mediated Loss of Autism-Associated CASPR2.","date":"2019","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/30843029","citation_count":49,"is_preprint":false},{"pmid":"32918359","id":"PMC_32918359","title":"Loss of Cntnap2 in the Rat Causes Autism-Related Alterations in Social Interactions, Stereotypic Behavior, and Sensory Processing.","date":"2020","source":"Autism research : official journal of the International Society for Autism Research","url":"https://pubmed.ncbi.nlm.nih.gov/32918359","citation_count":49,"is_preprint":false},{"pmid":"30076629","id":"PMC_30076629","title":"LGI1 and CASPR2 neurological autoimmunity in children.","date":"2018","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/30076629","citation_count":48,"is_preprint":false},{"pmid":"27439707","id":"PMC_27439707","title":"Eight further individuals with intellectual disability and epilepsy carrying bi-allelic CNTNAP2 aberrations allow delineation of the mutational and phenotypic spectrum.","date":"2016","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27439707","citation_count":48,"is_preprint":false},{"pmid":"29788201","id":"PMC_29788201","title":"Genetic variants in autism-related CNTNAP2 impair axonal growth of cortical neurons.","date":"2018","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29788201","citation_count":47,"is_preprint":false},{"pmid":"25867463","id":"PMC_25867463","title":"Clinical manifestations of patients with CASPR2 antibodies.","date":"2015","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/25867463","citation_count":47,"is_preprint":false},{"pmid":"30126973","id":"PMC_30126973","title":"Altered Auditory Processing, Filtering, and Reactivity in the Cntnap2 Knock-Out Rat Model for Neurodevelopmental Disorders.","date":"2018","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30126973","citation_count":47,"is_preprint":false},{"pmid":"27621318","id":"PMC_27621318","title":"Molecular Architecture of Contactin-associated Protein-like 2 (CNTNAP2) and Its Interaction with Contactin 2 (CNTN2).","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27621318","citation_count":44,"is_preprint":false},{"pmid":"26985448","id":"PMC_26985448","title":"Characterization of molecular and cellular phenotypes associated with a heterozygous CNTNAP2 deletion using patient-derived hiPSC neural cells.","date":"2015","source":"NPJ schizophrenia","url":"https://pubmed.ncbi.nlm.nih.gov/26985448","citation_count":44,"is_preprint":false},{"pmid":"34054814","id":"PMC_34054814","title":"Clinical Character of CASPR2 Autoimmune Encephalitis: A Multiple Center Retrospective Study.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34054814","citation_count":43,"is_preprint":false},{"pmid":"32595134","id":"PMC_32595134","title":"Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2.","date":"2020","source":"Practical neurology","url":"https://pubmed.ncbi.nlm.nih.gov/32595134","citation_count":42,"is_preprint":false},{"pmid":"22872700","id":"PMC_22872700","title":"Inherited genetic variants in autism-related CNTNAP2 show perturbed trafficking and ATF6 activation.","date":"2012","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22872700","citation_count":40,"is_preprint":false},{"pmid":"31352183","id":"PMC_31352183","title":"LGI1 and CASPR2 autoimmunity in children: Systematic literature review and report of a young girl with Morvan syndrome.","date":"2019","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/31352183","citation_count":39,"is_preprint":false},{"pmid":"25378149","id":"PMC_25378149","title":"Caspr and caspr2 are required for both radial and longitudinal organization of myelinated axons.","date":"2014","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25378149","citation_count":37,"is_preprint":false},{"pmid":"20394055","id":"PMC_20394055","title":"Language-related Cntnap2 gene is differentially expressed in sexually dimorphic song nuclei essential for vocal learning in songbirds.","date":"2010","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/20394055","citation_count":37,"is_preprint":false},{"pmid":"26185774","id":"PMC_26185774","title":"Caspr2 autoantibodies target multiple epitopes.","date":"2015","source":"Neurology(R) neuroimmunology & neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/26185774","citation_count":36,"is_preprint":false},{"pmid":"28572274","id":"PMC_28572274","title":"CASPR2 autoantibodies are raised during pregnancy in mothers of children with mental retardation and disorders of psychological development but not autism.","date":"2017","source":"Journal of neurology, neurosurgery, and psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/28572274","citation_count":35,"is_preprint":false},{"pmid":"35069805","id":"PMC_35069805","title":"Clinical characteristics, long-term functional outcomes and relapse of anti-LGI1/Caspr2 encephalitis: a prospective cohort study in Western China.","date":"2022","source":"Therapeutic advances in neurological disorders","url":"https://pubmed.ncbi.nlm.nih.gov/35069805","citation_count":35,"is_preprint":false},{"pmid":"28588433","id":"PMC_28588433","title":"Intragenic CNTNAP2 Deletions: A Bridge Too Far?","date":"2017","source":"Molecular syndromology","url":"https://pubmed.ncbi.nlm.nih.gov/28588433","citation_count":35,"is_preprint":false},{"pmid":"38319973","id":"PMC_38319973","title":"Ultrahigh frequencies of peripherally matured LGI1- and CASPR2-reactive B cells characterize the cerebrospinal fluid in autoimmune encephalitis.","date":"2024","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/38319973","citation_count":33,"is_preprint":false},{"pmid":"35253937","id":"PMC_35253937","title":"Human CASPR2 Antibodies Reversibly Alter Memory and the CASPR2 Protein Complex.","date":"2022","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/35253937","citation_count":33,"is_preprint":false},{"pmid":"22728895","id":"PMC_22728895","title":"Direct downregulation of CNTNAP2 by STOX1A is associated with Alzheimer's disease.","date":"2012","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/22728895","citation_count":33,"is_preprint":false},{"pmid":"26501174","id":"PMC_26501174","title":"Auditory processing and morphological anomalies in medial geniculate nucleus of Cntnap2 mutant mice.","date":"2015","source":"Behavioral neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26501174","citation_count":32,"is_preprint":false},{"pmid":"22752552","id":"PMC_22752552","title":"The juxtaparanodal proteins CNTNAP2 and TAG1 regulate diet-induced obesity.","date":"2012","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/22752552","citation_count":31,"is_preprint":false},{"pmid":"24147096","id":"PMC_24147096","title":"Defining the contribution of CNTNAP2 to autism susceptibility.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24147096","citation_count":31,"is_preprint":false},{"pmid":"25707359","id":"PMC_25707359","title":"Interaction proteomics of canonical Caspr2 (CNTNAP2) reveals the presence of two Caspr2 isoforms with overlapping interactomes.","date":"2015","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/25707359","citation_count":30,"is_preprint":false},{"pmid":"20711234","id":"PMC_20711234","title":"The CASPR2 cell adhesion molecule functions as a tumor suppressor gene in glioma.","date":"2010","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/20711234","citation_count":30,"is_preprint":false},{"pmid":"28966979","id":"PMC_28966979","title":"Developmental Disruption of GABAAR-Meditated Inhibition in Cntnap2 KO Mice.","date":"2017","source":"eNeuro","url":"https://pubmed.ncbi.nlm.nih.gov/28966979","citation_count":30,"is_preprint":false},{"pmid":"29264691","id":"PMC_29264691","title":"Expanding spectrum of contactin-associated protein 2 (CASPR2) autoimmunity-syndrome of parkinsonism and ataxia.","date":"2017","source":"Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/29264691","citation_count":30,"is_preprint":false},{"pmid":"35735209","id":"PMC_35735209","title":"Seizure underreporting in LGI1 and CASPR2 antibody encephalitis.","date":"2022","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/35735209","citation_count":27,"is_preprint":false},{"pmid":"35032032","id":"PMC_35032032","title":"CASPR2-IgG-associated autoimmune seizures.","date":"2022","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/35032032","citation_count":27,"is_preprint":false},{"pmid":"35247644","id":"PMC_35247644","title":"Contemporary advances in antibody-mediated encephalitis: anti-LGI1 and anti-Caspr2 antibody (Ab)-mediated encephalitides.","date":"2022","source":"Autoimmunity reviews","url":"https://pubmed.ncbi.nlm.nih.gov/35247644","citation_count":27,"is_preprint":false},{"pmid":"34489651","id":"PMC_34489651","title":"GABAB Receptor Agonist R-Baclofen Reverses Altered Auditory Reactivity and Filtering in the Cntnap2 Knock-Out Rat.","date":"2021","source":"Frontiers in integrative neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/34489651","citation_count":26,"is_preprint":false},{"pmid":"26097074","id":"PMC_26097074","title":"The role of candidate-gene CNTNAP2 in childhood apraxia of speech and specific language impairment.","date":"2015","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26097074","citation_count":25,"is_preprint":false},{"pmid":"28533267","id":"PMC_28533267","title":"The Kv1-associated molecules TAG-1 and Caspr2 are selectively targeted to the axon initial segment in hippocampal neurons.","date":"2017","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/28533267","citation_count":25,"is_preprint":false},{"pmid":"30376466","id":"PMC_30376466","title":"Cross-species models of attention-deficit/hyperactivity disorder and autism spectrum disorder: lessons from CNTNAP2, ADGRL3, and PARK2.","date":"2019","source":"Psychiatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30376466","citation_count":24,"is_preprint":false},{"pmid":"35483565","id":"PMC_35483565","title":"Somatosensory cortex hyperconnectivity and impaired whisker-dependent responses in Cntnap2-/- mice.","date":"2022","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/35483565","citation_count":23,"is_preprint":false},{"pmid":"31874168","id":"PMC_31874168","title":"Hyperactive Akt-mTOR pathway as a therapeutic target for pain hypersensitivity in Cntnap2-deficient mice.","date":"2019","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31874168","citation_count":23,"is_preprint":false},{"pmid":"37271769","id":"PMC_37271769","title":"CNTNAP2 intracellular domain (CICD) generated by γ-secretase cleavage improves autism-related behaviors.","date":"2023","source":"Signal transduction and targeted therapy","url":"https://pubmed.ncbi.nlm.nih.gov/37271769","citation_count":22,"is_preprint":false},{"pmid":"30724344","id":"PMC_30724344","title":"Acquired neuromyotonia in children with CASPR2 and LGI1 antibodies.","date":"2019","source":"Developmental medicine and child neurology","url":"https://pubmed.ncbi.nlm.nih.gov/30724344","citation_count":22,"is_preprint":false},{"pmid":"34484901","id":"PMC_34484901","title":"CASPR2-Related Morvan Syndrome: Autonomic, Polysomnographic, and Neuropsychological Observations.","date":"2021","source":"Neurology. Clinical practice","url":"https://pubmed.ncbi.nlm.nih.gov/34484901","citation_count":22,"is_preprint":false},{"pmid":"32906000","id":"PMC_32906000","title":"Coexistent MOG, NMDAR, CASPR2 antibody positivity: Triumph over the triumvirate.","date":"2020","source":"Multiple sclerosis and related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/32906000","citation_count":22,"is_preprint":false},{"pmid":"30017804","id":"PMC_30017804","title":"Genetic variants in the CNTNAP2 gene are associated with gender differences among dyslexic children in China.","date":"2018","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/30017804","citation_count":22,"is_preprint":false},{"pmid":"37001843","id":"PMC_37001843","title":"Loss of CNTNAP2 Alters Human Cortical Excitatory Neuron Differentiation and Neural Network Development.","date":"2023","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/37001843","citation_count":21,"is_preprint":false},{"pmid":"23818387","id":"PMC_23818387","title":"Distribution of language-related Cntnap2 protein in neural circuits critical for vocal learning.","date":"2014","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23818387","citation_count":20,"is_preprint":false},{"pmid":"32799011","id":"PMC_32799011","title":"Serum and CSF cytokine levels mirror different neuroimmunological mechanisms in patients with LGI1 and Caspr2 encephalitis.","date":"2020","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/32799011","citation_count":20,"is_preprint":false},{"pmid":"25977097","id":"PMC_25977097","title":"CASPR2 forms a complex with GPR37 via MUPP1 but not with GPR37(R558Q), an autism spectrum disorder-related mutation.","date":"2015","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25977097","citation_count":20,"is_preprint":false},{"pmid":"34953167","id":"PMC_34953167","title":"Objective sleep profile in LGI1/CASPR2 autoimmunity.","date":"2022","source":"Sleep","url":"https://pubmed.ncbi.nlm.nih.gov/34953167","citation_count":19,"is_preprint":false},{"pmid":"24726720","id":"PMC_24726720","title":"Caspr2 antibody limbic encephalitis is associated with Hashimoto thyroiditis and thymoma.","date":"2014","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/24726720","citation_count":19,"is_preprint":false},{"pmid":"30103974","id":"PMC_30103974","title":"Distinction between anti-VGKC-complex seropositive patients with and without anti-LGI1/CASPR2 antibodies.","date":"2018","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30103974","citation_count":19,"is_preprint":false},{"pmid":"26840208","id":"PMC_26840208","title":"Assembly of juxtaparanodes in myelinating DRG culture: Differential clustering of the Kv1/Caspr2 complex and scaffolding protein 4.1B.","date":"2016","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/26840208","citation_count":19,"is_preprint":false},{"pmid":"34271514","id":"PMC_34271514","title":"Altered cingulate structures and the associations with social awareness deficits and CNTNAP2 gene in autism spectrum disorder.","date":"2021","source":"NeuroImage. Clinical","url":"https://pubmed.ncbi.nlm.nih.gov/34271514","citation_count":18,"is_preprint":false},{"pmid":"28488276","id":"PMC_28488276","title":"CNTNAP2 is a direct FoxP2 target in vitro and in vivo in zebra finches: complex regulation by age and activity.","date":"2017","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/28488276","citation_count":18,"is_preprint":false},{"pmid":"28284582","id":"PMC_28284582","title":"The association of CNTNAP2 rs7794745 gene polymorphism and autism in Iranian population.","date":"2017","source":"Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia","url":"https://pubmed.ncbi.nlm.nih.gov/28284582","citation_count":17,"is_preprint":false},{"pmid":"35106542","id":"PMC_35106542","title":"Hyperexcitable and immature-like neuronal activity in the auditory cortex of adult rats lacking the language-linked CNTNAP2 gene.","date":"2022","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/35106542","citation_count":17,"is_preprint":false},{"pmid":"28370195","id":"PMC_28370195","title":"Axonal domain disorganization in Caspr1 and Caspr2 mutant myelinated axons affects neuromuscular junction integrity, leading to muscle atrophy.","date":"2017","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/28370195","citation_count":17,"is_preprint":false},{"pmid":"37183190","id":"PMC_37183190","title":"Genotype-phenotype correlation in contactin-associated protein-like 2 (CNTNAP-2) developmental disorder.","date":"2023","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37183190","citation_count":16,"is_preprint":false},{"pmid":"22133810","id":"PMC_22133810","title":"Cntnap2 expression in the cerebellum of Foxp2(R552H) mice, with a mutation related to speech-language disorder.","date":"2011","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/22133810","citation_count":16,"is_preprint":false},{"pmid":"25413786","id":"PMC_25413786","title":"Guillain-Barré syndrome associated with CASPR2 antibodies: two paediatric cases.","date":"2014","source":"Journal of the peripheral nervous system : JPNS","url":"https://pubmed.ncbi.nlm.nih.gov/25413786","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52166,"output_tokens":8098,"usd":0.138984},"stage2":{"model":"claude-opus-4-6","input_tokens":11843,"output_tokens":4672,"usd":0.264022},"total_usd":0.403006,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"Caspr2 (CNTNAP2) is required to maintain Kv1 (Shaker-like K+) channels at the juxtaparanodal region of myelinated axons, and this clustering depends on the interaction of Caspr2 with TAG-1 (an immunoglobulin-like cell adhesion molecule that binds Caspr2), forming a scaffold that organizes ion channels in the axonal membrane through axon-glia interactions.\",\n      \"method\": \"Gene-targeted knockout mice, immunostaining, co-localization studies\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular phenotype, replicated across multiple studies\",\n      \"pmids\": [\"12963709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Caspr2 localization to the juxtaparanodal region depends on axon-glia interactions and the formation of paranodal barriers; in the absence of paranodal adhesion (CGT-/- or contactin KO mice), Caspr2 and Kv1.2 fail to relocate to juxtaparanodes and instead remain at paranodes, demonstrating that Caspr-containing barriers control the positioning of Caspr2.\",\n      \"method\": \"Analysis of mutant mice (CGT-/- and contactin KO) with immunostaining and developmental time-course experiments\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple mutant mouse models, defined cellular phenotype, mechanistic epistasis\",\n      \"pmids\": [\"11567047\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Caspr2 clusters Kv1 channels at the juxtaparanodal region via its cytoplasmic domain but not via its carboxy-terminal PDZ-binding motif; PSD-93 and PSD-95 accumulate at the juxtaparanode in a Caspr2- and TAG-1-dependent manner; Caspr2 interacts with distinct scaffolding proteins through both PDZ- and protein 4.1-binding sequences as revealed by proteomics.\",\n      \"method\": \"Transgenic rescue experiments with deletion mutants (Caspr2dCT, Caspr2dPDZ) in Caspr2-null mice; co-immunoprecipitation; proteomic analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — transgenic mutagenesis with functional rescue, proteomics, multiple orthogonal methods\",\n      \"pmids\": [\"19109503\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PSD-93, but not Caspr2, is required for clustering Kv1 channels at the axon initial segment (AIS); Caspr2 mediates Kv1 channel clustering at the juxtaparanode through a distinct mechanism independent of PSD-93.\",\n      \"method\": \"PSD-93 knockdown by RNAi in hippocampal neurons; PSD-93-/- knockout mice; comparison with Caspr2-null mice\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO mice with defined cellular phenotype, genetic epistasis between PSD-93 and Caspr2\",\n      \"pmids\": [\"18509034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The interaction of Caspr2 with protein 4.1B is required for the accumulation of Caspr2 and Kv1 channels at the juxtaparanodal axonal membrane; a Caspr2 transgene lacking the 4.1B-binding sequence (Caspr2-d4.1) does not accumulate at the juxtaparanode, and Kv1 channels are not clustered at the juxtaparanode in 4.1B-null mice.\",\n      \"method\": \"Transgenic rescue experiments with 4.1-binding domain deletion mutants in Caspr2-null mice; analysis of 4.1B-null mice\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — transgenic domain-deletion rescue plus KO validation, multiple orthogonal approaches\",\n      \"pmids\": [\"20164332\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Caspr2 is targeted to the axonal surface through selective somatodendritic endocytosis; internalization from dendrites and cell body is dynamin-dependent and requires a PKC substrate motif at Thr1292 within the 4.1B-binding domain, as mutation of this residue or PKC inhibition prevents somatodendritic internalization.\",\n      \"method\": \"HA-tagged Caspr2 in hippocampal neurons, dominant-negative dynamin-1 or Dynasore treatment, site-directed mutagenesis (T1292 mutant), live-cell imaging\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis combined with pharmacological and dominant-negative approaches, functional readout\",\n      \"pmids\": [\"19706678\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Both Caspr and Caspr2 together are required for the radial (mesaxonal line) and longitudinal organization of Kv1 channels along myelinated peripheral axons; in Caspr/Caspr2 double-null mice, Kv1 channels are dispersed along the axolemma rather than confined to the internodal line, and nodes of Ranvier are widened, revealing compensatory functions between the two proteins.\",\n      \"method\": \"Double knockout mice (caspr-/-/caspr2-/-), immunostaining, comparison with single mutants\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — double KO genetic epistasis, defined cellular phenotype\",\n      \"pmids\": [\"25378149\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Cntnap2 knockout mice show neuronal migration abnormalities, reduced number of cortical interneurons, and abnormal neuronal network activity prior to seizure onset, establishing a functional role for CNTNAP2 in brain development including interneuron positioning.\",\n      \"method\": \"Cntnap2-/- knockout mouse characterization; neuropathological analysis, EEG recording, behavioral testing\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with multiple defined cellular and circuit phenotypes, highly cited foundational study\",\n      \"pmids\": [\"21962519\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Autism-associated CNTNAP2 missense variants cause aberrant protein trafficking; the D1129H mutant is retained in the endoplasmic reticulum through interaction with ER chaperones (BiP/Grp78, Calnexin, ERp57) and activates the ATF6 branch of the unfolded protein response and proteasomal degradation; the 1253* frameshift mutation produces a secreted soluble protein lacking membrane anchorage.\",\n      \"method\": \"Immunofluorescence confocal microscopy and biochemical analysis in HEK-293 cells and hippocampal neurons; co-immunoprecipitation with ER chaperones; UPR pathway analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis with multiple orthogonal biochemical methods, functional consequence demonstrated\",\n      \"pmids\": [\"22872700\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The ectodomain of CNTNAP2 consists of three lobes (large, medium, small) with distinct domain assignments, and binds directly and specifically to contactin 2 (CNTN2) with low nanomolar affinity; autism-associated mutations are distributed throughout the entire ectodomain rather than clustering in a single region.\",\n      \"method\": \"Electron microscopy of CNTNAP2 protein with epitope labeling, domain fragment analysis, direct binding assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structural EM and quantitative binding assay with mutagenesis context\",\n      \"pmids\": [\"27621318\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CNTNAP2 plays a dose-dependent role in axon growth; loss of one Cntnap2 allele is sufficient to reduce axonal growth in cortical neurons; ASD missense variants I869T and G731S (with impaired TAG-1/Contactin2 binding) do not rescue axonal growth deficits; R1119H (which causes ER retention) has a dominant-negative effect via oligomerization with wild-type Caspr2; N407S also exerts a dominant-negative effect on axon growth despite normal membrane localization.\",\n      \"method\": \"Cortical neuron cultures from mouse embryos; heterozygous genetic background rescue assays; ASD missense variant functional analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro functional rescue assays with multiple ASD variants, dominant-negative mechanism demonstrated by oligomerization\",\n      \"pmids\": [\"29788201\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Caspr2 autoantibodies inhibit the interaction of Caspr2 with contactin-2 (nanomolar affinity interaction confirmed by solid-phase binding assay) but do not cause internalization of surface Caspr2 in hippocampal neurons or transfected HEK cells; functional blocking of this cell adhesion molecule interaction is proposed as the pathogenic mechanism of IgG4 autoantibodies.\",\n      \"method\": \"Solid-phase binding assay, cell-based assay, cell-surface biotinylation, Western blot, live neuron cultures\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro binding reconstitution with quantitative affinity measurement, multiple cell systems tested\",\n      \"pmids\": [\"29244234\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Either immune- or genetic-mediated loss of CASPR2 enhances primary afferent excitability through regulation of Kv1 channel expression at the DRG soma membrane; passive transfer of patient CASPR2 autoantibodies into mice causes mechanical pain hypersensitivity in a peripherally restricted manner without neural injury; Cntnap2-/- mice show increased DRG neuron excitability and enhanced nociceptive transmission in dorsal horn.\",\n      \"method\": \"Passive transfer of human autoantibodies into mice; Cntnap2-/- KO mice; in vivo and ex vivo electrophysiology; Kv1 channel quantification\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — passive transfer model plus KO mice, electrophysiological mechanistic readouts, mechanistic convergence\",\n      \"pmids\": [\"29429934\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Caspr2 is expressed at excitatory synapses in the cortex; knockdown of Caspr2 in vitro or in vivo decreases synaptic expression of AMPA receptors and amplitude of AMPA receptor-mediated currents, and blocks both synaptic scaling in vitro and experience-dependent homeostatic synaptic plasticity in visual cortex; patient CASPR2 antibodies decrease dendritic Caspr2 levels and synaptic AMPA receptor trafficking.\",\n      \"method\": \"In vitro siRNA knockdown; in vivo knockdown; whole-cell electrophysiology; AMPA receptor trafficking assays; patient antibody treatment of neurons\",\n      \"journal\": \"Cerebral cortex\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (KD in vitro and in vivo, electrophysiology, antibody treatment), mechanistic pathway defined\",\n      \"pmids\": [\"30843029\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"New dendritic spines in Cntnap2-/- mice are formed at normal rates but fail to stabilize, while rates of spine elimination are unaltered, revealing a specific role for CNTNAP2 in stabilizing new synaptic contacts in vivo.\",\n      \"method\": \"In vivo two-photon spine imaging in Cntnap2-/- knockout mice\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular phenotype, single lab\",\n      \"pmids\": [\"25951243\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Cntnap2-/- mice show selective reduction in perisomatic (but not dendritic) evoked IPSCs onto CA1 pyramidal cells, with normal excitatory transmission and normal miniature IPSC frequency and amplitude but increased spontaneous action potential-driven IPSCs, indicating Cntnap2 deletion selectively impairs perisomatic hippocampal inhibition.\",\n      \"method\": \"Whole-cell electrophysiology in acute hippocampal slices from Cntnap2-/- mice\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined electrophysiological phenotype, single lab\",\n      \"pmids\": [\"26511255\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Cntnap2 knockout mice show a dramatic decrease in excitatory and inhibitory synaptic inputs onto L2/3 pyramidal neurons of the medial prefrontal cortex, with reduced spines and synapses, increased activity in inhibitory neurons in vivo, and reduced phase-locking to delta and theta oscillations despite normal dendritic complexity and intrinsic excitability.\",\n      \"method\": \"Laser-scanning photostimulation, whole-cell recordings, electron microscopy, in vivo local field potential and unit recording\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (in vitro and in vivo electrophysiology, EM), mechanistic circuit phenotype defined\",\n      \"pmids\": [\"31141683\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Loss of Cntnap2 causes profound deficiency in clustering of Kv1-family potassium channels at juxtaparanodes of brain myelinated axons, alters axonal action potential waveform, increases postsynaptic excitatory responses, and delays the normal process of cortical myelination.\",\n      \"method\": \"Cntnap2-/- mouse electrophysiology, immunostaining of myelinated axons, developmental myelination analysis\",\n      \"journal\": \"Cerebral cortex\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mice with electrophysiological and anatomical mechanistic readouts, multiple parameters assessed\",\n      \"pmids\": [\"29300891\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Cntnap2 cell-autonomously regulates the physiology of parvalbumin (PV)+, fast-spiking cortical interneurons; human ASD missense mutations in CNTNAP2 impair PV+ interneuron development; somatostatin+ regular-spiking interneurons are not affected.\",\n      \"method\": \"Transplantation assay of MGE-derived interneurons into wild-type brain; constitutive Cntnap2 null mice; in vivo testing of human ASD missense alleles\",\n      \"journal\": \"Cerebral cortex\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-autonomous demonstration via transplantation assay, multiple human variants tested\",\n      \"pmids\": [\"29028946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Interaction proteomics reveals the Caspr2 interactome includes CNTN2, Kv1 channels (KCNAs), ADAM family members (ADAM22, ADAM23, ADAM11), LGI family members, and MAGUKs (DLGs, MPPs); a short isoform of Caspr2 lacking most extracellular domains still associates with ADAM22, LGI1, and Kv1 channels; Caspr2 is enriched in lipid rafts and synaptic membrane but depleted from the postsynaptic density.\",\n      \"method\": \"Co-immunoprecipitation/interaction proteomics; subcellular fractionation; Western blot\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mass spectrometry-based interactome, single lab\",\n      \"pmids\": [\"25707359\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CASPR2 forms a tripartite complex with GPR37 and MUPP1 in the mouse brain; CASPR2 interacts with the PDZ3 domain of MUPP1, and GPR37 interacts with the PDZ11 domain; the ASD-related GPR37(R558Q) mutation impairs binding to MUPP1 and prevents cell-surface transport by MUPP1, causing ER retention and loss of synaptic co-localization with CASPR2 and MUPP1 in hippocampal neurons.\",\n      \"method\": \"Co-immunoprecipitation from mouse brain; cell-based assay; immunofluorescence in primary hippocampal neurons; domain-deletion and point-mutation analysis\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP from brain plus cell-based functional assay, single lab\",\n      \"pmids\": [\"25977097\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Cntnap2-/- mice show hyperactive Akt-mTOR signaling in the hippocampus; treatment with Akt inhibitor LY294002 or mTOR inhibitor rapamycin rescues social deficits (but not hyperactivity or repetitive behaviors) in Cntnap2-/- mice, identifying dysregulated Akt-mTOR as a pathway downstream of CNTNAP2 loss.\",\n      \"method\": \"RNA sequencing, biochemical pathway analysis, pharmacological rescue in Cntnap2-/- mice\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pathway identified by transcriptomics and confirmed by pharmacological rescue, single lab\",\n      \"pmids\": [\"30816216\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CNTNAP2 is cleaved by γ-secretase to produce a CNTNAP2 intracellular domain (CICD); CICD promotes nuclear translocation of CASK to regulate transcription of Necdin; viral delivery of CICD to the mPFC of Cntnap2-/- mice rescues social and repetitive behavior deficits; Necdin deficiency reduces social interaction, and viral Necdin expression in mPFC rescues social preference in Cntnap2-/- mice, defining a CNTNAP2-CASK-Necdin signaling pathway.\",\n      \"method\": \"Biochemical γ-secretase cleavage assay; viral CICD delivery; nuclear translocation assays; behavioral rescue; Necdin rescue in mPFC\",\n      \"journal\": \"Signal transduction and targeted therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — biochemical cleavage assay, in vivo viral rescue, pathway mechanistically defined, single lab\",\n      \"pmids\": [\"37271769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"STOX1A, a forkhead-related transcription factor, directly downregulates CNTNAP2 as identified by chromatin immunoprecipitation coupled to shotgun cloning.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) with shotgun cloning; gene expression analysis\",\n      \"journal\": \"Journal of Alzheimer's disease\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single ChIP experiment, single lab, limited mechanistic follow-up\",\n      \"pmids\": [\"22728895\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Experimental downregulation of FoxP2 in zebra finch Area X using lentiviral vectors reduces Cntnap2 expression; FoxP2 binds to and activates the avian CNTNAP2 promoter in vitro; natural downregulation of FoxP2 by age or singing also downregulates Cntnap2, establishing CNTNAP2 as a direct transcriptional target of FOXP2.\",\n      \"method\": \"Lentiviral FoxP2 knockdown in vivo; luciferase promoter assay in vitro; in situ hybridization; qPCR\",\n      \"journal\": \"Genes, brain, and behavior\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro promoter assay plus in vivo knockdown, ortholog context (songbird), multiple methods\",\n      \"pmids\": [\"28488276\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Infusion of patients' IgG (anti-CASPR2 encephalitis) into mouse cerebroventricles causes memory impairment, reduces surface CASPR2 clusters, decreases CASPR2/TAG-1 co-localization (demonstrated by STED super-resolution microscopy), and lowers hippocampal Kv1.1 and GluA1 levels; in cultured neurons, patients' IgG selectively internalizes CASPR2 without affecting TAG-1; all effects are reversible upon IgG removal.\",\n      \"method\": \"Intracerebroventricular IgG infusion mouse model; STED super-resolution microscopy; confocal quantification of Kv1.1 and GluA1; behavioral tests; cultured neuron internalization assay\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vivo passive transfer with super-resolution structural validation, multiple functional readouts, reversibility demonstrated\",\n      \"pmids\": [\"35253937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In cultured hippocampal neurons, the LNG2-EGF1 modules in the Caspr2 ectodomain and the cytoplasmic PDZ-binding site regulate axonal positioning; deletion of LNG2-EGF1 promotes AIS localization and association with TAG-1; the PDZ-binding site can elicit AIS enrichment and recruit MPP2; Caspr2 and TAG-1 are co-sorted in axonal transport vesicles.\",\n      \"method\": \"Live-cell imaging; deletion construct analysis; co-transport vesicle imaging in hippocampal neurons\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — domain-deletion mutagenesis combined with live-cell imaging, single lab\",\n      \"pmids\": [\"28533267\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Caspr2 autoantibodies from limbic encephalitis patients are directed against the N-terminal Discoidin and LamininG1 modules; in live hippocampal neuron cultures, these antibodies selectively target inhibitory interneurons (GAD65-positive axons and VGAT-positive presynaptic contacts), and may induce alteration of Gephyrin clusters at inhibitory synapses; Caspr2-Fc chimera binding to hippocampal neurons requires TAG-1 as a receptor.\",\n      \"method\": \"Domain-deletion mapping; live immunolabeling of hippocampal neurons; Caspr2-Fc chimera binding assay; comparison with TAG-1-deficient mouse neurons\",\n      \"journal\": \"Frontiers in cellular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — domain mapping plus functional cell-based assay, single lab\",\n      \"pmids\": [\"26217189\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Assembly of juxtaparanodal Kv1/Caspr2 complex during myelination requires protein 4.1B: in 4.1B KO myelinating DRG cultures and sciatic nerves, Caspr2 fails to be properly targeted early during myelination; Caspr2 and Kv1 channels transiently accumulate at the nodal region before relocalizing to juxtaparanodes; Kv1 channels display asymmetric enrichment at distal juxtaparanodes.\",\n      \"method\": \"Myelinating DRG/Schwann cell co-cultures; 4.1B KO mice; photobleaching (FRAP) of paranodal Caspr; adenoviral Caspr-GFP expression\",\n      \"journal\": \"Glia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse plus in vitro myelinating cultures, FRAP analysis, single lab\",\n      \"pmids\": [\"26840208\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Disorganization of axonal domains in Caspr2 single mutants (and Caspr1/Caspr2 double mutants) in peripheral myelinated axons disrupts neuromuscular junction integrity, leading to NMJ denervation, reduced postsynaptic endplate areas, and muscle fiber degeneration with mitochondrial dysfunction in double mutants.\",\n      \"method\": \"Single and double Caspr1/Caspr2 knockout mice; NMJ immunostaining; muscle histology; electron microscopy\",\n      \"journal\": \"Journal of neuroscience research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — double KO genetic epistasis, defined cellular and tissue phenotype, single lab\",\n      \"pmids\": [\"28370195\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Cntnap2 is expressed in all primary sensory organs and in distinct brain regions involved in different sensory modalities; Cntnap2-/- mice exhibit abnormal sensory responses, including lack of preference for novel odors in olfaction-based tasks, linking Caspr2 loss throughout the sensory system to sensory manifestations.\",\n      \"method\": \"Caspr2:tau-LacZ knock-in reporter mouse; behavioral olfactory testing of Cntnap2-/- mice\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — knock-in reporter plus KO behavioral phenotype, single lab\",\n      \"pmids\": [\"26647347\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Cntnap2-/- mice exhibit a decrease in oxytocin immunoreactive neurons in the paraventricular nucleus of the hypothalamus and overall decreased brain oxytocin levels; acute oxytocin administration or activation of endogenous oxytocin neurons via DREADD rescues social deficits; chronic early postnatal oxytocin treatment leads to more lasting behavioral recovery and restores oxytocin immunoreactivity in the PVN.\",\n      \"method\": \"Oxytocin immunostaining, ELISA for brain oxytocin; pharmacological rescue; DREADD-based chemogenetic activation of PVN oxytocin neurons in Cntnap2-/- mice\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods (immunostaining, ELISA, pharmacology, chemogenetics), functional pathway defined in KO mice\",\n      \"pmids\": [\"25609168\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Patient-derived forebrain organoids with homozygous CNTNAP2 protein-truncating mutation display increased volume and cell number driven by increased neural progenitor proliferation; PFC-excitatory neurons are the key CNTNAP2-expressing cell type; organoid overgrowth phenotype is rescued by CRISPR-Cas9 correction of the mutation.\",\n      \"method\": \"iPSC-derived forebrain organoids; single-cell RNA sequencing; CRISPR-Cas9 correction; cell proliferation assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — isogenic CRISPR correction, single-cell transcriptomics, functional rescue, multiple orthogonal methods\",\n      \"pmids\": [\"34471112\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CNTNAP2/Caspr2 is a large multidomain neurexin-family transmembrane cell adhesion molecule that: (1) forms a complex with TAG-1 (contactin-2) at the axonal juxtaparanodal region to cluster Kv1 potassium channels, requiring its cytoplasmic domain's interaction with protein 4.1B for membrane localization; (2) undergoes PKC-dependent somatodendritic endocytosis to achieve polarized axonal surface expression; (3) is transcriptionally regulated by FOXP2; (4) is cleaved by γ-secretase to release an intracellular domain (CICD) that translocates CASK to the nucleus to drive Necdin transcription, thereby regulating social behavior; (5) is required for normal cortical interneuron (especially PV+) development, dendritic spine stabilization, AMPA receptor synaptic expression and homeostatic plasticity, and cortical myelination; and (6) when absent causes hyperactive Akt-mTOR signaling and dysregulated oxytocin neuron function, while autoantibodies targeting its extracellular domain block its interaction with contactin-2 and trigger internalization of CASPR2 with downstream loss of Kv1 channels and AMPA receptors, causing encephalitis and neuropathic pain.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CNTNAP2 (Caspr2) is a neurexin-superfamily transmembrane cell adhesion molecule that organizes axonal domains, regulates synaptic function, and controls cortical development. At myelinated axons, Caspr2 forms a complex with contactin-2/TAG-1 and, through its cytoplasmic protein 4.1B-binding domain, clusters Kv1 potassium channels at the juxtaparanodal region, thereby shaping axonal excitability and action potential waveform [PMID:12963709, PMID:20164332, PMID:29300891]. At excitatory synapses, Caspr2 stabilizes newly formed dendritic spines, maintains synaptic AMPA receptor expression, and is required for homeostatic synaptic scaling; its intracellular domain, released by γ-secretase cleavage, translocates CASK to the nucleus to drive Necdin transcription and regulate social behavior [PMID:30843029, PMID:25951243, PMID:37271769]. Loss of CNTNAP2 causes reduced cortical interneurons (particularly parvalbumin-positive), neuronal migration abnormalities, hyperactive Akt-mTOR signaling, decreased hypothalamic oxytocin, and increased neural progenitor proliferation, while patient autoantibodies against the Caspr2 ectodomain internalize surface Caspr2, disrupt contactin-2 binding, and reduce Kv1 channels and GluA1, causing autoimmune encephalitis and neuropathic pain [PMID:21962519, PMID:29028946, PMID:35253937, PMID:29429934].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Before Caspr2's function was known at the node of Ranvier, analysis of paranodal adhesion mutants established that the juxtaparanodal positioning of Caspr2 and Kv1.2 depends on intact paranodal barriers, revealing that axon-glia interactions gate Caspr2 localization.\",\n      \"evidence\": \"Immunostaining in CGT-/- and contactin-KO mice with developmental time-course\",\n      \"pmids\": [\"11567047\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which paranodal barriers exclude Caspr2 not defined\", \"Whether Caspr2 is actively transported or passively excluded was unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Gene-targeted deletion of Caspr2 established it as the essential organizer for juxtaparanodal Kv1 channel clustering and demonstrated that this function requires the Caspr2–TAG-1 interaction, defining the core adhesion complex at the juxtaparanode.\",\n      \"evidence\": \"Cntnap2 knockout mice with immunostaining and co-localization studies\",\n      \"pmids\": [\"12963709\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which Caspr2 domains mediate Kv1 recruitment was unknown\", \"Trans vs. cis interaction with TAG-1 not resolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Transgenic rescue with domain-deletion mutants resolved that the Caspr2 cytoplasmic domain (not the PDZ-binding motif) is essential for Kv1 clustering, and that PSD-93/PSD-95 accumulate at juxtaparanodes in a Caspr2-dependent manner, while PSD-93 independently clusters Kv1 at the AIS.\",\n      \"evidence\": \"Caspr2-null mice rescued with Caspr2ΔCT or Caspr2ΔPDZ transgenes; PSD-93 KO and RNAi\",\n      \"pmids\": [\"19109503\", \"18509034\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise scaffolding contacts between Caspr2 cytoplasmic domain and Kv1 subunits not identified\", \"Role of individual MAGUK family members at juxtaparanode not dissected\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"The mechanism of Caspr2 axonal polarization was revealed to be selective somatodendritic endocytosis rather than directed axonal transport, requiring dynamin and a PKC-phosphorylatable residue (Thr1292) within the 4.1B-binding domain.\",\n      \"evidence\": \"HA-tagged Caspr2 in hippocampal neurons with dominant-negative dynamin, Dynasore, T1292 mutagenesis, and live-cell imaging\",\n      \"pmids\": [\"19706678\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the PKC isoform phosphorylating T1292 not determined\", \"Whether this mechanism operates in vivo during myelination not shown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"The requirement for protein 4.1B in Caspr2 membrane retention was demonstrated: a Caspr2 transgene lacking the 4.1B-binding sequence and 4.1B-null mice both fail to accumulate Caspr2 and Kv1 at juxtaparanodes, establishing 4.1B as a critical cytoskeletal anchor.\",\n      \"evidence\": \"Transgenic rescue with Caspr2-Δ4.1 in Caspr2-null mice; 4.1B-null mice\",\n      \"pmids\": [\"20164332\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether 4.1B links Caspr2 to spectrin-actin cytoskeleton directly or through intermediaries not resolved\", \"Redundancy with other 4.1 family members not fully tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Beyond its role at axonal domains, Cntnap2 knockout mice revealed a developmental function: reduced cortical interneurons, neuronal migration abnormalities, and abnormal network activity prior to seizure onset, establishing Caspr2 as a regulator of cortical circuit assembly.\",\n      \"evidence\": \"Cntnap2-/- mice with neuropathological analysis, EEG, behavioral testing\",\n      \"pmids\": [\"21962519\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-autonomous vs. non-autonomous mechanism of interneuron loss not determined at this stage\", \"Molecular pathway linking Caspr2 to migration not identified\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Autism-associated CNTNAP2 missense variants were shown to cause pathology through protein misfolding: D1129H is retained in the ER via chaperone interactions and activates the ATF6 UPR branch, while the 1253* frameshift produces a secreted, untethered protein, revealing loss-of-function mechanisms at the protein level.\",\n      \"evidence\": \"Confocal microscopy and co-immunoprecipitation in HEK-293 cells and hippocampal neurons\",\n      \"pmids\": [\"22872700\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ER-retained variants exert gain-of-function toxicity via chronic UPR activation not tested in vivo\", \"Prevalence of trafficking-defective variants among all ASD-associated CNTNAP2 alleles unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Multiple studies converged to define Caspr2's synaptic and circuit-level roles: it stabilizes new dendritic spines, selectively supports perisomatic inhibition, and its interactome includes ADAM22/23, LGI family, Kv1 channels, and MAGUKs; separately, loss of Cntnap2 causes reduced hypothalamic oxytocin neurons and brain oxytocin, with oxytocin administration rescuing social deficits.\",\n      \"evidence\": \"In vivo two-photon spine imaging; hippocampal slice electrophysiology; interaction proteomics/co-IP; oxytocin immunostaining, ELISA, DREADD chemogenetics in Cntnap2-/- mice\",\n      \"pmids\": [\"25951243\", \"26511255\", \"25707359\", \"25609168\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Caspr2 mechanistically stabilizes spines (signaling pathway) unknown\", \"Whether oxytocin deficit is cell-autonomous or circuit-level consequence not resolved\", \"Functional significance of ADAM22/LGI1 interaction for Caspr2 not tested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"ASD-associated CNTNAP2 missense variants I869T and G731S (impaired TAG-1 binding) fail to rescue axon growth in haploinsufficient neurons, while R1119H exerts a dominant-negative effect through oligomerization with wild-type Caspr2, demonstrating dose-dependent and dominant-negative pathogenic mechanisms.\",\n      \"evidence\": \"Cortical neuron cultures from heterozygous Cntnap2+/- mouse embryos with variant rescue assays\",\n      \"pmids\": [\"29788201\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Oligomerization interface enabling dominant-negative effect not structurally defined\", \"In vivo consequences of heterozygous ASD variants not characterized\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Structural characterization of the Caspr2 ectodomain by EM revealed a three-lobed architecture that binds contactin-2 with low-nanomolar affinity; autism-associated mutations are distributed throughout the ectodomain rather than clustering in one binding interface.\",\n      \"evidence\": \"Electron microscopy with epitope labeling; domain fragment binding assays\",\n      \"pmids\": [\"27621318\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution structure not available\", \"Which ectodomain surface contacts contactin-2 not mapped\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Caspr2 was shown to cell-autonomously regulate PV+ fast-spiking interneuron physiology but not somatostatin+ interneurons, and separately, passive transfer of patient CASPR2 autoantibodies into mice demonstrated that immune-mediated Caspr2 loss enhances DRG excitability and causes neuropathic pain through peripheral Kv1 channel dysregulation.\",\n      \"evidence\": \"MGE-derived interneuron transplantation into wild-type brain; passive transfer of patient IgG; Cntnap2-/- DRG electrophysiology\",\n      \"pmids\": [\"29028946\", \"29429934\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Caspr2 controls PV+ interneuron maturation at the molecular level unknown\", \"Whether peripheral and central autoantibody effects are mechanistically distinct not resolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Caspr2 autoantibodies were shown to block the Caspr2–contactin-2 interaction at nanomolar sensitivity, identifying functional disruption of this adhesion complex as the primary pathogenic mechanism of IgG4 autoantibodies in encephalitis.\",\n      \"evidence\": \"Solid-phase binding assay; cell-surface biotinylation in hippocampal neurons and HEK cells\",\n      \"pmids\": [\"29244234\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether different epitope specificities of patient antibodies produce different clinical phenotypes not tested\", \"Complement-independent vs. complement-dependent pathology not dissected\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Caspr2's synaptic role was extended to excitatory synapses: knockdown reduces synaptic AMPA receptor expression and blocks homeostatic synaptic scaling both in vitro and in visual cortex in vivo; patient antibodies phenocopy this by internalizing dendritic Caspr2 and reducing AMPA receptor trafficking.\",\n      \"evidence\": \"siRNA knockdown in vitro and in vivo; whole-cell electrophysiology; AMPA receptor trafficking assays; patient antibody treatment\",\n      \"pmids\": [\"30843029\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism linking Caspr2 to AMPA receptor insertion/retention unknown\", \"Whether Caspr2-dependent homeostatic plasticity operates at all cortical synapses or is layer-specific not determined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Loss of Cntnap2 profoundly reduces both excitatory and inhibitory synaptic inputs onto mPFC L2/3 pyramidal neurons despite normal dendritic morphology and intrinsic excitability, and disrupts cortical myelination timing and axonal action potential waveform, revealing convergent circuit-level consequences.\",\n      \"evidence\": \"Laser-scanning photostimulation, in vivo electrophysiology, EM in Cntnap2-/- mice; developmental myelination analysis\",\n      \"pmids\": [\"31141683\", \"29300891\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether myelination delay is secondary to altered neuronal activity or a direct glial effect of Caspr2 loss unknown\", \"Relationship between mPFC circuit changes and behavioral phenotypes not causally tested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Patient-derived forebrain organoids with homozygous CNTNAP2 truncation revealed increased neural progenitor proliferation and organoid overgrowth, rescued by CRISPR correction, identifying a human-relevant role for CNTNAP2 in controlling progenitor expansion in PFC-excitatory neuron lineages.\",\n      \"evidence\": \"iPSC-derived forebrain organoids; scRNA-seq; CRISPR-Cas9 isogenic correction\",\n      \"pmids\": [\"34471112\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signaling pathway by which Caspr2 restrains progenitor proliferation not identified\", \"Whether this phenotype occurs in heterozygous patient cells not tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"In vivo infusion of patient anti-CASPR2 IgG confirmed a unified autoimmune mechanism: antibodies internalize surface Caspr2, disrupt Caspr2/TAG-1 co-localization (by STED), and reduce both Kv1.1 and GluA1, with full reversibility upon IgG removal, establishing the downstream molecular cascade of autoantibody-mediated encephalitis.\",\n      \"evidence\": \"Intracerebroventricular IgG infusion; STED super-resolution microscopy; behavioral testing; cultured neuron internalization assay\",\n      \"pmids\": [\"35253937\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether antibody-induced internalization proceeds via the same PKC/dynamin pathway as physiological somatodendritic endocytosis unknown\", \"Long-term irreversible synaptic damage thresholds not defined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"A non-canonical signaling function was discovered: γ-secretase cleavage of Caspr2 releases an intracellular domain (CICD) that translocates CASK to the nucleus to activate Necdin transcription, with viral CICD or Necdin delivery to mPFC rescuing social deficits in Cntnap2-/- mice.\",\n      \"evidence\": \"Biochemical γ-secretase cleavage assay; viral CICD and Necdin rescue in mPFC of Cntnap2-/- mice; nuclear translocation assays\",\n      \"pmids\": [\"37271769\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"γ-secretase cleavage regulation and stimulus-dependence not characterized\", \"Independent replication of CICD nuclear signaling pathway needed\", \"Whether CICD signaling operates at juxtaparanodes or only at synapses unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the atomic-resolution structure of the Caspr2–contactin-2 complex, the signaling pathway by which Caspr2 controls neural progenitor proliferation and interneuron migration, the precise mechanism linking Caspr2 to AMPA receptor synaptic retention, and whether the γ-secretase/CICD/CASK/Necdin pathway is broadly operative across brain regions.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No atomic-resolution structure of Caspr2 or Caspr2–CNTN2 complex\", \"Signaling cascade from Caspr2 to progenitor proliferation control not identified\", \"Mechanism of AMPA receptor stabilization by Caspr2 at the molecular level unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [0, 9, 11]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [2, 4, 19]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1, 5, 26]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [22]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 2, 7, 13, 15, 17]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [21, 22]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [7, 18, 32]},\n      {\"term_id\": \"R-HSA-1500931\", \"supporting_discovery_ids\": [0, 9, 11]}\n    ],\n    \"complexes\": [\n      \"Caspr2/TAG-1(CNTN2)/Kv1 juxtaparanodal complex\",\n      \"Caspr2/ADAM22/LGI1 complex\",\n      \"Caspr2/GPR37/MUPP1 complex\"\n    ],\n    \"partners\": [\n      \"CNTN2\",\n      \"EPB41L3\",\n      \"ADAM22\",\n      \"LGI1\",\n      \"CASK\",\n      \"DLG1\",\n      \"MPP2\",\n      \"MPDZ\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}